F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
185 days
| 10 |
102.6 |
mg/dl |
1.8 |
5.69 |
blood glucose analysis |
tail vein |
|
|
0 |
|
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11480 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
153.0 |
mg/dl |
5.4 |
17.91 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11436 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
252.0 |
mg/dl |
7.2 |
23.88 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11438 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
65 days
| 11 |
0.0 |
mg/dl |
0.0 |
0.0 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
|
67622 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
86.4 |
mg/dl |
3.6 |
11.94 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11453 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum triglyceride level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood triglyceride amount |
male |
185 days
| 10 |
191.15 |
mg/dl |
12.39 |
39.18 |
serum triglyceride analysis |
tail vein |
|
|
0 |
|
Vitros TRIG slides (Johnson & Johnson, Rochester, NY) |
11474 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum total cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood cholesterol amount |
male |
185 days
| 10 |
89.19 |
mg/dl |
3.09 |
9.77 |
serum total cholesterol measurement test |
tail vein |
|
|
0 |
|
Vitros CHOL slides (Johnson & Johnson, Rochester, NY) |
11477 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
body weight |
control condition (for 185 days) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
body mass |
male |
185 days
| 10 |
35.0 |
g |
6.0 |
18.97 |
body weighing method |
|
0.0 |
|
0 |
|
|
11485 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
129.6 |
mg/dl |
3.6 |
11.94 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11433 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
body weight |
control condition (for 95 days) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
body mass |
male |
95 days
| 11 |
27.0 |
g |
6.0 |
19.9 |
body weighing method |
|
0.0 |
|
0 |
|
|
11443 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
333.0 |
mg/dl |
14.4 |
47.76 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11442 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
95 days
| 11 |
0.05 |
mg/dl |
0.01 |
0.04 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
30 |
min |
|
67638 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum high density lipoprotein cholesterol level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood HDL cholesterol amount |
male |
185 days
| 10 |
41.7 |
mg/dl |
1.54 |
4.88 |
serum high-density lipoprotein-cholesterol measurement test |
tail vein |
|
|
0 |
|
N-geneous HDL-c kit (Biomed-RK, Jonkoping, Sweden) |
11472 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
104.4 |
mg/dl |
3.6 |
11.94 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11430 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
88.2 |
mg/dl |
1.8 |
5.97 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
60 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11455 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
body weight |
control condition (for 65 days) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
body mass |
male |
65 days
| 11 |
197.0 |
g |
5.0 |
16.58 |
body weighing method |
|
0.0 |
|
0 |
|
|
11464 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
epididymal fat pad weight |
control condition |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
epididymal fat pad mass |
male |
185 days
| 10 |
10.2 |
g |
0.4 |
1.26 |
post excision weight measurement |
|
|
|
0 |
|
|
11482 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
95 days
| 11 |
18200.0 |
(mg/dl) x min |
509.09 |
1688.46 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11448 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
95 days
| 11 |
0.05 |
mg/dl |
0.01 |
0.04 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
15 |
min |
|
67635 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level area under curve (AUC) |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
13600.0 |
(mg/dl) x min |
327.27 |
1085.44 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
90 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11468 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
65 days
| 11 |
0.03 |
mg/dl |
0.0 |
0.01 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
15 |
min |
|
67626 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
189.0 |
mg/dl |
7.2 |
23.88 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
30 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11459 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
65 days
| 11 |
0.02 |
mg/dl |
0.0 |
0.01 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
30 |
min |
|
67629 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
95 days
| 11 |
0.01 |
mg/dl |
0.0 |
0.01 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
|
67631 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
serum insulin level |
fasting (between 6 and 7 hours) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood insulin amount |
male |
185 days
| 10 |
0.03 |
mg/dl |
0.0 |
0.01 |
enzyme linked immunosorbent assay |
tail vein |
0.0 |
|
0 |
|
|
67645 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
84.6 |
mg/dl |
1.8 |
5.97 |
intraperitoneal glucose tolerance test |
tail vein |
0.0 |
post glucose injection |
0 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11449 |
85 |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
blood glucose level |
fasting (between 6 and 7 hours) then glucose solution (2 g/kg) |
Galli J, et al., Diabetes 1999 Dec;48(12):2463-70. |
blood glucose amount |
male |
65 days
| 11 |
309.6 |
mg/dl |
9.0 |
29.85 |
intraperitoneal glucose tolerance test |
tail vein |
|
post glucose injection |
15 |
min |
Reflolux II; BM-test Glycemie I-44 reagent strips (Boeringer-Mannheim, Germany) |
11462 |
85 |